Disclosure 0001193125-26-368285-1

SEC FORM 4

$937,957.49

Rapport Therapeutics, Inc. (RAPP)

Sale of 18,921 shares at $49.5723 per share.

Reporting Person Ceesay Abraham · Officer Title Chief Executive Officer · Transaction Code S

Traded Aug 25, 2026 · Disclosed Aug 26, 2026

Source: SEC Form 4 · 0001193125-26-368285 · filed 2026-08-26 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Rapport Therapeutics, Inc. (RAPP)." Disclosed 2026-08-26. https://desqlong.com/cards/0001193125-26-368285-1 (retrieved 2026-09-26).